Piedmont Investment Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,777	Closed	-$3K	–	1710
2018 Q2	$3K	Buy	+1,777	New	+$3K	﹤0.01%	2398